- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-08
DOI
10.1186/s13045-023-01405-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RNA sensing via the RIG‐I‐like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency
- (2022) Jorn E Stok et al. EMBO JOURNAL
- Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
- (2022) Antonella Padella et al. Journal of Hematology & Oncology
- Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure
- (2022) Nicholas J. Short et al. Journal of Hematology & Oncology
- A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma
- (2022) Cecilia Monge et al. ONCOLOGIST
- The actin nucleator Spir-1 is a virus restriction factor that promotes innate immune signalling
- (2022) Alice A. Torres et al. PLoS Pathogens
- Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
- (2022) Chaoyuan Kuang et al. Clinical Epigenetics
- Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection
- (2022) Hongjuan You et al. Frontiers in Immunology
- Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
- (2022) Meghali Goswami et al. Journal for ImmunoTherapy of Cancer
- Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
- (2022) Sean C. Semple et al. Pharmaceutics
- The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β
- (2022) Lan Gong et al. Microbiology Spectrum
- Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
- (2022) V. Moreno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
- (2022) Markus W. Löffler et al. CLINICAL CANCER RESEARCH
- Emerging role of RNA sensors in tumor microenvironment and immunotherapy
- (2022) Rui Yang et al. Journal of Hematology & Oncology
- Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
- (2022) Minru Liao et al. Journal of Hematology & Oncology
- Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses
- (2022) Bingfeng Zuo et al. Journal of Hematology & Oncology
- Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
- (2022) Mengling Wu et al. Journal of Hematology & Oncology
- Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
- (2022) Yangfu Jiang et al. Journal of Hematology & Oncology
- How we treat NK/T-cell lymphomas
- (2022) Eric Tse et al. Journal of Hematology & Oncology
- PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
- (2022) Qin Wu et al. Nature Chemical Biology
- Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
- (2022) Michael Lim et al. NEURO-ONCOLOGY
- Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
- (2022) Antonio Omuro et al. NEURO-ONCOLOGY
- Cooperative effects of RIG-I-like receptor signaling and IRF1 on DNA damage-induced cell death
- (2022) David Y. Zander et al. Cell Death & Disease
- Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
- (2022) Adel Samson et al. Cancer Immunology Research
- Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
- (2022) Boya Peng et al. Journal of Extracellular Vesicles
- A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy
- (2022) Yu Zhang et al. Experimental Hematology & Oncology
- Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial
- (2022) Maartje W. Rohaan et al. BMC CANCER
- Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors
- (2022) Mercedes Porosnicu et al. Future Oncology
- HPV type‐specific trends in cervical precancers in the United States, 2008–2016
- (2022) Julia W. Gargano et al. INTERNATIONAL JOURNAL OF CANCER
- Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
- (2022) Wan-Hong Zhao et al. Journal of Hematology & Oncology
- First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
- (2022) Xin Jin et al. Journal of Hematology & Oncology
- Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
- (2022) David Kegyes et al. Journal of Hematology & Oncology
- ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation
- (2022) Richard de Reuver et al. NATURE
- Microbiota and lung cancer
- (2022) Taichiro Goto SEMINARS IN CANCER BIOLOGY
- Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
- (2022) Huanzhen Ni et al. Nature Communications
- Opposing effects of deubiquitinase OTUD3 in innate immunity against RNA and DNA viruses
- (2022) Xiaolian Cai et al. Cell Reports
- Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
- (2022) Dionysis Papadatos-Pastos et al. Journal for ImmunoTherapy of Cancer
- CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models
- (2022) Anthony Cheung et al. Cancers
- Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer
- (2022) Tao Xu et al. Frontiers in Oncology
- Helicobacter pylori actively suppresses innate immune nucleic acid receptors
- (2022) Samuel D.R. Dooyema et al. Gut Microbes
- LGP2 is essential for zebrafish survival through dual regulation of IFN antiviral response
- (2022) Xiu-Ying Gong et al. iScience
- Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
- (2022) Nicolas Vabret et al. iScience
- Pembrolizumab versus cetuximab, concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase 2 trial
- (2022) Y. Tao et al. ANNALS OF ONCOLOGY
- Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activity
- (2022) Johannes Lutz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Actin cytoskeleton remodeling primes RIG-I-like receptor activation
- (2022) Dhiraj Acharya et al. CELL
- Global burden of HPV ‐attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis
- (2022) Ashish A. Deshmukh et al. INTERNATIONAL JOURNAL OF CANCER
- Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery
- (2022) Christoph M. Zimmermann et al. JOURNAL OF CONTROLLED RELEASE
- Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
- (2022) Maud Toulmonde et al. Journal of Hematology & Oncology
- Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease
- (2022) Razan Mohty et al. Journal of Hematology & Oncology
- Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
- (2022) Ming Yi et al. Journal of Hematology & Oncology
- Pattern Recognition Receptors of Nucleic Acids Can Cause Sublethal Activation of the Mitochondrial Apoptosis Pathway during Viral Infection
- (2022) Sylwia Gradzka-Boberda et al. JOURNAL OF VIROLOGY
- Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs
- (2022) Sijin Luozhong et al. NANO LETTERS
- Mammalian genome innovation through transposon domestication
- (2022) Andrew J. Modzelewski et al. NATURE CELL BIOLOGY
- Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
- (2022) Martina Musella et al. NATURE IMMUNOLOGY
- Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
- (2022) Ji-nuo Wang et al. Experimental Hematology & Oncology
- CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
- (2022) Xuanqi Cao et al. Experimental Hematology & Oncology
- Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
- (2022) Peiling Zhang et al. Experimental Hematology & Oncology
- The molecular basis of immuno-radiotherapy
- (2022) Ioannis M. Koukourakis et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
- (2022) Zhenyang Li et al. Journal of Hematology & Oncology
- RIG-I contributes to dsDNA-induced innate immune activation in human brain microvascular endothelial cells
- (2022) Zicheng Huang et al. MOLECULAR IMMUNOLOGY
- Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade
- (2022) Liam F. Spurr et al. Nature Cancer
- Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
- (2021) Li Zhou et al. Nature Communications
- The mitochondrial protein ERAL1 suppresses RNA virus infection by facilitating RIG-I-like receptor signaling
- (2021) Siji Li et al. Cell Reports
- Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes
- (2021) Sooyoung Lee et al. iScience
- Efficacy of decitabine plus anti-PD-1 camrelizumab in patients with Hodgkin lymphoma who progressed or relapsed after PD-1 blockade monotherapy
- (2021) Chunmeng Wang et al. CLINICAL CANCER RESEARCH
- The emerging role of KDM5A in human cancer
- (2021) Guan-Jun Yang et al. Journal of Hematology & Oncology
- Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity
- (2021) Elizabeth S. Levy et al. MOLECULAR PHARMACEUTICS
- Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance
- (2021) Marco Tigano et al. NATURE
- Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
- (2021) Molly C. Holbrook et al. Cancers
- SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion
- (2021) Shu Yang et al. Experimental Hematology & Oncology
- Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
- (2021) Johannes P. W. Heidbuechel et al. Journal of Hematology & Oncology
- Intratumoural administration and tumour tissue targeting of cancer immunotherapies
- (2021) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Reciprocal regulation of RIG-I and XRCC4 connects DNA repair with RIG-I immune signaling
- (2021) Guijie Guo et al. Nature Communications
- Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns
- (2021) Daniel J Laydon et al. BMJ Open
- Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner
- (2021) Andreas Linder et al. Frontiers in Immunology
- Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma
- (2021) Yang Liu et al. Journal for ImmunoTherapy of Cancer
- A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia
- (2021) Kapil Saxena et al. CANCER
- Epigenetic therapies in ovarian cancer alter repetitive element expression in a TP53-dependent manner
- (2021) James I. McDonald et al. CANCER RESEARCH
- The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function
- (2021) Lexus R. Johnson et al. CELL
- Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses
- (2021) Qiannan Tang et al. IMMUNITY
- Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
- (2021) Farhad Ravandi et al. Journal of Hematology & Oncology
- Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
- (2021) Ming Yi et al. Journal of Hematology & Oncology
- Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors
- (2021) Jian Li et al. Journal of Hematology & Oncology
- Targeting Akt in cancer for precision therapy
- (2021) Hui Hua et al. Journal of Hematology & Oncology
- Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration
- (2021) Thomas Clapes et al. NATURE CELL BIOLOGY
- The IGF-1 Signaling Pathway in Viral Infections
- (2021) Agata Józefiak et al. Viruses-Basel
- The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
- (2021) Lars Ny et al. Nature Communications
- ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation
- (2021) Richard de Reuver et al. Cell Reports
- Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation
- (2021) Yong Shen et al. Cell Reports
- RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination
- (2021) Ziwei Yang et al. eLife
- Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
- (2021) Salma K. Jabbour et al. JAMA Oncology
- Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers
- (2021) Mark Stasiewicz et al. Cancers
- Nucleic Acid Sensing in the Tumor Vasculature
- (2021) Adrian M. Baris et al. Cancers
- Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice
- (2021) Oliver Oey et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Interferon Signaling in Estrogen Receptor–positive Breast Cancer: A Revitalized Topic
- (2021) Xiaoyong Fu et al. ENDOCRINOLOGY
- Combination strategies to maximize the benefits of cancer immunotherapy
- (2021) Shaoming Zhu et al. Journal of Hematology & Oncology
- Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
- (2021) Wantao Wu et al. Journal of Hematology & Oncology
- The US3 Kinase of Herpes Simplex Virus Phosphorylates the RNA Sensor RIG-I To Suppress Innate Immunity
- (2021) Michiel van Gent et al. JOURNAL OF VIROLOGY
- Cellular origins of dsRNA, their recognition and consequences
- (2021) Y. Grace Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Herpes Simplex Virus Type 1 Infection Disturbs the Mitochondrial Network, Leading to Type I Interferon Production through the RNA Polymerase III/RIG-I Pathway
- (2021) Noémie Berry et al. mBio
- NUDT2 initiates viral RNA degradation by removal of 5′-phosphates
- (2021) Beatrice T. Laudenbach et al. Nature Communications
- Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
- (2021) Masmudur M. Rahman et al. Cancers
- Oncolytic viruses for triple negative breast cancer and beyond
- (2021) Shengye Jin et al. Biomarker Research
- The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy
- (2020) Michele Sommariva et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Radiotherapy and immunotherapy for cancer: From "systemic" to "multi-site"
- (2020) Ainhoa Arina et al. CLINICAL CANCER RESEARCH
- Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
- (2020) Mark S. Ferguson et al. MOLECULAR THERAPY
- Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway
- (2020) Kazuhiro Murai et al. Scientific Reports
- USP27X negatively regulates antiviral signaling by deubiquitinating RIG-I
- (2020) Xinyue Tao et al. PLoS Pathogens
- N6-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I
- (2020) Mijia Lu et al. Nature Microbiology
- Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
- (2020) Ciara M. Kelly et al. JAMA Oncology
- The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I
- (2020) Francesca Bufalieri et al. Cancers
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- N6-Methyladenosine Modification of Hepatitis B and C Viral RNAs Attenuates Host Innate Immunity via RIG-I Signaling
- (2020) Geon-Woo Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Spatiotemporal dynamics of innate immune signaling via RIG-I–like receptors
- (2020) Katharina Esser-Nobis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIG-I-like receptor LGP2 is required for tumor control by radiation therapy
- (2020) Wenxin Zheng et al. CANCER RESEARCH
- Decitabine/Cedazuridine: First Approval
- (2020) Sohita Dhillon DRUGS
- Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
- (2020) Karim Fizazi et al. EUROPEAN UROLOGY
- Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency
- (2020) Parinaz Mehdipour et al. NATURE
- Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors
- (2020) Iván Márquez-Rodas et al. Science Translational Medicine
- Poly-ICLC, a multi-functional immune modulator for treating cancer
- (2020) Hussein Sultan et al. SEMINARS IN IMMUNOLOGY
- The Ubiquitin E3 Ligase Parkin Inhibits Innate Antiviral Immunity Through K48-Linked Polyubiquitination of RIG-I and MDA5
- (2020) Lang Bu et al. Frontiers in Immunology
- Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
- (2020) Hussein Sultan et al. Journal for ImmunoTherapy of Cancer
- Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti-PD-(L)1 therapy
- (2020) Matthew D. Hellmann et al. CLINICAL CANCER RESEARCH
- BRLF1 suppresses RNA Pol III‐mediated RIG‐I inflammasome activation in the early EBV lytic lifecycle
- (2020) Xubing Long et al. EMBO REPORTS
- Dual targeting of G9a and DNMT1 for the treatment of experimental cholangiocarcinoma
- (2020) Leticia Colyn et al. HEPATOLOGY
- ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation
- (2020) Mengjie Hu et al. JOURNAL OF CLINICAL INVESTIGATION
- RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
- (2019) Simon Heidegger et al. EBioMedicine
- NDR2 promotes the antiviral immune response via facilitating TRIM25-mediated RIG-I activation in macrophages
- (2019) Zhiyong Liu et al. Science Advances
- The enhanced tumor specificity of TG6002, an armed-oncolytic vaccinia virus deleted in two genes involved in nucleotide metabolism
- (2019) Johann Foloppe et al. Molecular Therapy-Oncolytics
- Activation of RIG-I signaling to increase the pro-inflammatory phenotype of a tumor
- (2019) David L. Elion et al. Oncotarget
- Activation of innate immunity by mitochondrial dsRNA in mouse cells lacking p53 protein.
- (2019) Dagmara M. Wiatrek et al. RNA
- The role of regulatory T cells in the response to radiation therapy in head and neck cancer
- (2019) Ayman J Oweida et al. JNCI-Journal of the National Cancer Institute
- DFMO and 5-azacytidine increase M1 macrophages in the tumor microenvironment of murine ovarian cancer.
- (2019) Meghan Travers et al. CANCER RESEARCH
- Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
- (2019) Weina Zhang et al. CELL
- RNA Helicase LGP2 Negatively Regulates RIG-I Signaling by Preventing TRIM25-Mediated Caspase Activation and Recruitment Domain Ubiquitination
- (2019) Kendra M. Quicke et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
- (2019) Cristina Segovia et al. NATURE MEDICINE
- Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
- (2019) Willemijn S. M. E. Theelen et al. JAMA Oncology
- Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
- (2019) Jayesh A. Kulkarni et al. ACCOUNTS OF CHEMICAL RESEARCH
- An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation
- (2019) Luciano Castiello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial
- (2019) Anna Maria Di Giacomo et al. CLINICAL CANCER RESEARCH
- Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer
- (2019) Jhanelle E. Gray et al. CLINICAL CANCER RESEARCH
- Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia
- (2019) Georgina S. Daher-Reyes et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Type I IFN protects cancer cells from CD8+ T cell–mediated cytotoxicity after radiation
- (2019) Jianzhou Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Utility of the RIG-I agonist triphosphate RNA for melanoma therapy
- (2019) Mike W Helms et al. MOLECULAR CANCER THERAPEUTICS
- LGP2 binds to PACT to regulate RIG-I– and MDA5-mediated antiviral responses
- (2019) Raul Y. Sanchez David et al. Science Signaling
- Attenuation of the Innate Immune Response against Viral Infection Due to ZNF598-Promoted Binding of FAT10 to RIG-I
- (2019) Guanming Wang et al. Cell Reports
- RIG-I activation is critical for responsiveness to checkpoint blockade
- (2019) Simon Heidegger et al. Science Immunology
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
- (2019) Devalingam Mahalingam et al. CLINICAL CANCER RESEARCH
- Repurposing the yellow fever vaccine for intratumoral immunotherapy
- (2019) Maria Angela Aznar et al. EMBO Molecular Medicine
- cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
- (2019) Zining Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses
- (2019) Xiaodong Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
- (2019) Michael Ruzicka et al. LEUKEMIA
- N6-Methyladenosine Modification Controls Circular RNA Immunity
- (2019) Y. Grace Chen et al. MOLECULAR CELL
- Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade
- (2019) Tala Shekarian et al. Science Translational Medicine
- 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases
- (2019) Soham Gupta et al. PLoS Pathogens
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Stimulation of Innate Immunity by Host and Viral RNAs
- (2019) Felix Streicher et al. TRENDS IN IMMUNOLOGY
- Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
- (2019) Catherine de Martel et al. Lancet Global Health
- The RIG‐I‐like receptor LGP2 inhibits Dicer‐dependent processing of long double‐stranded RNA and blocks RNA interference in mammalian cells
- (2018) Annemarthe G van der Veen et al. EMBO JOURNAL
- Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma
- (2018) Marina Bárcena-Varela et al. HEPATOLOGY
- Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
- (2018) Dewan Md Sakib Hossain et al. JOURNAL OF CLINICAL INVESTIGATION
- Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy
- (2018) Penelope A. Bradbury et al. LUNG CANCER
- PARP1 depletion induces RIG-I-dependent signaling in human cancer cells
- (2018) Rajib Ghosh et al. PLoS One
- The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
- (2018) Janine Kimpel et al. Viruses-Basel
- MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation
- (2018) Peipei Zhou et al. Nature Communications
- Latent Membrane Protein 1 of Epstein–Barr Virus Promotes RIG-I Degradation Mediated by Proteasome Pathway
- (2018) Chongfeng Xu et al. Frontiers in Immunology
- A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
- (2018) Devalingam Mahalingam et al. Cancers
- Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer
- (2018) Lujun Chen et al. Cancer Cell International
- Dual inhibition of DNA and histone methyltransferases increases viral mimicry in ovarian cancer cells
- (2018) Minmin Liu et al. CANCER RESEARCH
- Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity towards autologous melanoma cells
- (2018) Juliane Daßler-Plenker et al. INTERNATIONAL JOURNAL OF CANCER
- Mitochondrial double-stranded RNA triggers antiviral signalling in humans
- (2018) Ashish Dhir et al. NATURE
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- USP14 promotes K63-linked RIG-I deubiquitination and suppresses antiviral immune responses
- (2018) Hongrui Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer
- (2018) Manisit Das et al. MOLECULAR THERAPY
- Nuclear cGAS suppresses DNA repair and promotes tumorigenesis
- (2018) Haipeng Liu et al. NATURE
- Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
- (2018) Jeffrey J. Ishizuka et al. NATURE
- RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection
- (2018) Yang Zhao et al. Nature Communications
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study
- (2018) Naval Daver et al. Cancer Discovery
- Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia
- (2017) Trinna L. Cuellar et al. JOURNAL OF CELL BIOLOGY
- RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer
- (2017) Houbao Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Innate immunity to RNA virus is regulated by temporal and reversible sumoylation of RIG-I and MDA5
- (2017) Ming-Ming Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
- (2017) Sébastien A. Felt et al. JOURNAL OF GENERAL VIROLOGY
- Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
- (2017) Yuanjun Lu et al. Journal of Innate Immunity
- Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
- (2017) Udaya S. Rangaswamy et al. JOURNAL OF VIROLOGY
- 5′-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells
- (2017) Dengzhe Li et al. LEUKEMIA RESEARCH
- Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening
- (2017) Joschka Willemsen et al. MOLECULAR CELL
- Sensing Self and Foreign Circular RNAs by Intron Identity
- (2017) Y. Grace Chen et al. MOLECULAR CELL
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
- (2017) Alessandra Zevini et al. TRENDS IN IMMUNOLOGY
- Double-stranded DNA induces a prothrombotic phenotype in the vascular endothelium
- (2017) Erik Gaitzsch et al. Scientific Reports
- The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I
- (2017) Chunyuan Zhao et al. Cell Reports
- The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry
- (2017) Hongjuan Zhao et al. Clinical Epigenetics
- The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
- (2016) Xinwei Cheng et al. ADVANCED DRUG DELIVERY REVIEWS
- Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9
- (2016) Lili Deng et al. CANCER LETTERS
- HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I
- (2016) S. J. Choi et al. EMBO JOURNAL
- Ubiquitination of the Transcription Factor IRF-3 Activates RIPA, the Apoptotic Pathway that Protects Mice from Viral Pathogenesis
- (2016) Saurabh Chattopadhyay et al. IMMUNITY
- TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity
- (2016) Xueting Lang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
- (2016) Anne M Noonan et al. MOLECULAR THERAPY
- RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation
- (2016) Wendie Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
- (2016) Minmin Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling
- (2016) Ann Fiegen Durbin et al. mBio
- Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
- (2016) Diana Rose E. Ranoa et al. Oncotarget
- Current and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform
- (2016) Andrew B. Satterlee et al. Theranostics
- Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies
- (2016) Leo L. Wang et al. Advanced Healthcare Materials
- RIG-I activation induces the release of extracellular vesicles with antitumor activity
- (2016) Juliane Daßler-Plenker et al. OncoImmunology
- Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
- (2016) Catherine Dold et al. Molecular Therapy-Oncolytics
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Poxvirus Decapping Enzymes Enhance Virulence by Preventing the Accumulation of dsRNA and the Induction of Innate Antiviral Responses
- (2015) Shin-Wu Liu et al. Cell Host & Microbe
- A non‐canonical role of the p97 complex in RIG‐I antiviral signaling
- (2015) Qian Hao et al. EMBO JOURNAL
- Retinoic acid-inducible gene 1 and sensing of hepatitis B virus revisited
- (2015) Eloi R. Verrier et al. HEPATOLOGY
- DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity
- (2015) Anetta Härtlova et al. IMMUNITY
- The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
- (2015) Seiichi Sato et al. IMMUNITY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
- (2015) Alex K. K. Leung et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Anti-angiogenic efficacy of 5′-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs
- (2015) Dongmei Yuan et al. Oncotarget
- RIOK3-Mediated Phosphorylation of MDA5 Interferes with Its Assembly and Attenuates the Innate Immune Response
- (2015) Ken Takashima et al. Cell Reports
- Cytoplasmic sensing of viral nucleic acids
- (2015) Matthias Habjan et al. Current Opinion in Virology
- Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
- (2014) Mirjam C. Boelens et al. CELL
- Up-regulation of the interferon-related genes inBRCA2knockout epithelial cells
- (2014) Hong Xu et al. JOURNAL OF PATHOLOGY
- MDA5 and LGP2: Accomplices and Antagonists of Antiviral Signal Transduction
- (2014) K. R. Rodriguez et al. JOURNAL OF VIROLOGY
- TRIM13 Is a Negative Regulator of MDA5-Mediated Type I Interferon Production
- (2014) K. Narayan et al. JOURNAL OF VIROLOGY
- RIG-I Modulates Src-Mediated AKT Activation to Restrain Leukemic Stemness
- (2014) Xian-Yang Li et al. MOLECULAR CELL
- Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates
- (2014) Delphine Goubau et al. NATURE
- RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation
- (2014) R. C. Widau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity
- (2014) K. Kuniyoshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward a crystal-clear view of the viral RNA sensing and response by RIG-I-like receptors
- (2014) Dahai Luo RNA Biology
- The Ubiquitin-Specific Protease USP15 Promotes RIG-I-Mediated Antiviral Signaling by Deubiquitylating TRIM25
- (2014) E.-K. Pauli et al. Science Signaling
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma
- (2013) Jin Hou et al. CANCER CELL
- Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells
- (2013) Joanne Y. H. Lim et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Efficacy of Bifunctional siRNA Combining TGF- 1 Silencing with RIG-I Activation in Pancreatic Cancer
- (2013) J. Ellermeier et al. CANCER RESEARCH
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
- (2013) Mara Roxana Rubinstein et al. Cell Host & Microbe
- USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors
- (2013) Jun Cui et al. CELL RESEARCH
- Dephosphorylation of the RNA Sensors RIG-I and MDA5 by the Phosphatase PP1 Is Essential for Innate Immune Signaling
- (2013) Effi Wies et al. IMMUNITY
- Poly(I:C) exhibits an anti-cancer effect in human gastric adenocarcinoma cells which is dependent on RLRs
- (2013) Jing Qu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Multifunctional antitumor molecule 5′-triphosphate siRNA combining glutaminase silencing and RIG-I activation
- (2013) Gang Meng et al. INTERNATIONAL JOURNAL OF CANCER
- Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors
- (2013) Scott A. Gerber et al. INTERNATIONAL JOURNAL OF CANCER
- Melanoma Differentiation-Associated Gene 5 Senses Hepatitis B Virus and Activates Innate Immune Signaling To Suppress Virus Replication
- (2013) H.-L. Lu et al. JOURNAL OF IMMUNOLOGY
- Cell Type-Specific Subcellular Localization of Phospho-TBK1 in Response to Cytoplasmic Viral DNA
- (2013) Takayuki Suzuki et al. PLoS One
- Small non-coding RNAs encoded within the herpes simplex virus type 1 latency associated transcript (LAT) cooperate with the retinoic acid inducible gene I (RIG-I) to induce beta-interferon promoter activity and promote cell survival
- (2013) Leticia Frizzo da Silva et al. VIRUS RESEARCH
- MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades
- (2013) Siqi Liu et al. eLife
- Endothelial RIG-I activation impairs endothelial function
- (2012) Tobias Asdonk et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
- (2012) E. M. Karapanagiotou et al. CLINICAL CANCER RESEARCH
- TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles
- (2012) T. Matsushima-Miyagi et al. CLINICAL CANCER RESEARCH
- Ubiquitin-Induced Oligomerization of the RNA Sensors RIG-I and MDA5 Activates Antiviral Innate Immune Response
- (2012) Xiaomo Jiang et al. IMMUNITY
- Herpes Simplex Virus 1 Tegument Protein US11 Downmodulates the RLR Signaling Pathway via Direct Interaction with RIG-I and MDA-5
- (2012) J. Xing et al. JOURNAL OF VIROLOGY
- MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells
- (2012) Qian Feng et al. Cell Reports
- Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I
- (2012) Gretja Schnell et al. PLoS Pathogens
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
- (2011) B. C. Burnette et al. CANCER RESEARCH
- Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
- (2011) Eva Kowalinski et al. CELL
- Structural Insights into RNA Recognition by RIG-I
- (2011) Dahai Luo et al. CELL
- MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response
- (2011) Fajian Hou et al. CELL
- Expression of pattern recognition receptors in liver biopsy specimens of children chronically infected with HBV and HCV
- (2011) Iwona Mozer-Lisewska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I
- (2011) H. Oshiumi et al. JOURNAL OF BIOCHEMISTRY
- Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
- (2011) Marina Caskey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Conventional Protein Kinase C- (PKC- ) and PKC- Negatively Regulate RIG-I Antiviral Signal Transduction
- (2011) N. P. Maharaj et al. JOURNAL OF VIROLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation
- (2011) Lin-Jia Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA species generated in vaccinia virus infected cells activate cell type-specific MDA5 or RIG-I dependent interferon gene transcription and PKR dependent apoptosis
- (2011) Chad Myskiw et al. VIROLOGY
- Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity
- (2010) Wenwen Zeng et al. CELL
- The Ubiquitin Ligase Riplet Is Essential for RIG-I-Dependent Innate Immune Responses to RNA Virus Infection
- (2010) Hiroyuki Oshiumi et al. Cell Host & Microbe
- A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
- (2010) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3
- (2010) R. Valentine et al. JOURNAL OF GENERAL VIROLOGY
- Phosphorylation of RIG-I by Casein Kinase II Inhibits Its Antiviral Response
- (2010) Z. Sun et al. JOURNAL OF VIROLOGY
- MDA5 is SUMOylated by PIAS2β in the upregulation of Type I interferon signaling
- (2010) Jihuan Fu et al. MOLECULAR IMMUNOLOGY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I
- (2010) Yanli Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses
- (2010) T. Satoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
- (2009) Yu-Hsin Chiu et al. CELL
- Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
- (2009) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Extracellular and Intracellular Pattern Recognition Receptors Cooperate in the Recognition of Helicobacter pylori
- (2009) Roland Rad et al. GASTROENTEROLOGY
- The Double-stranded RNA Binding Domain of the Vaccinia Virus E3L Protein Inhibits Both RNA- and DNA-induced Activation of Interferon β
- (2009) Jean-Baptiste Marq et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
- (2009) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate
- (2009) Andrea Ablasser et al. NATURE IMMUNOLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- REUL Is a Novel E3 Ubiquitin Ligase and Stimulator of Retinoic-Acid-Inducible Gene-I
- (2009) Dong Gao et al. PLoS One
- A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA
- (2009) M. K. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors
- (2008) Shuo Peng et al. CANCER SCIENCE
- The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response
- (2008) Constantin S Friedman et al. EMBO REPORTS
- Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle
- (2008) Yoshifumi Kawaguchi et al. INTERNATIONAL JOURNAL OF CANCER
- Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-β Induction during the Early Phase of Viral Infection
- (2008) Hiroyuki Oshiumi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5
- (2008) Hiroki Kato et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Nonself RNA-Sensing Mechanism of RIG-I Helicase and Activation of Antiviral Immune Responses
- (2008) Kiyohiro Takahasi et al. MOLECULAR CELL
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now